Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Cancer Res Treat
; 54(4): 1240-1255, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35038826
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fibromatosis, Aggressive
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Res Treat
Year:
2022
Type:
Article